IL13RA2 and glioma: Minor changes in the CNV plots were not assessed due to the decreased quality as we used FFPE samples and an increased unreliability of signal normalization on X and Y chromosomes, although recurrent amplification of IL13RA2 on chromosome X might be of interest as it has recently been described to be a biomarker in glioma patients [30].